| Year |
Citation |
Score |
| 2024 |
Aldecoa I, Barroeta I, Carroll SL, Fortea J, Gilmore A, Ginsberg SD, Guzman SJ, Hamlett ED, Head E, Perez SE, Potter H, Molina-Porcel L, Raha-Chowdhury R, Wisniewski T, Yong WH, et al. Down Syndrome Biobank Consortium: A perspective. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38270275 DOI: 10.1002/alz.13692 |
0.645 |
|
| 2022 |
Li P, Wu Y, Hamlett ED, Goodwin AJ, Halushka PV, Carroll SL, Liu M, Fan H. Suppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 35038582 DOI: 10.1016/j.ymthe.2022.01.023 |
0.478 |
|
| 2020 |
Emre C, Hjorth E, Bharani K, Carroll S, Granholm AC, Schultzberg M. Receptors for pro-resolving mediators are increased in Alzheimer's disease brain. Brain Pathology (Zurich, Switzerland). PMID 31912564 DOI: 10.1111/Bpa.12812 |
0.586 |
|
| 2019 |
Bharani KL, Ledreux A, Gilmore A, Carroll SL, Granholm AC. Serum pro-BDNF levels correlate with phospho-tau staining in Alzheimer's disease. Neurobiology of Aging. PMID 31882186 DOI: 10.1016/J.Neurobiolaging.2019.11.010 |
0.58 |
|
| 2019 |
Haytural H, Mermelekas G, Emre C, Nigam SM, Carroll SL, Winblad B, Bogdanovic N, Barthet G, Granholm AC, Orre LM, Tjernberg LO, Frykman S. The proteome of the dentate terminal zone of the perforant path indicates presynaptic impairment in Alzheimer disease. Molecular & Cellular Proteomics : McP. PMID 31699905 DOI: 10.1074/Mcp.Ra119.001737 |
0.592 |
|
| 2018 |
Choi S, Won JS, Carroll SL, Annamalai B, Singh I, Singh AK. Pathology of nNOS expressing GABAergic neurons in mouse model of Alzheimer's disease. Neuroscience. PMID 29782905 DOI: 10.1016/J.Neuroscience.2018.05.013 |
0.301 |
|
| 2016 |
Hamlett ED, Goetzl EJ, Ledreux A, Vasilevko V, Boger HA, LaRosa A, Clark D, Carroll SL, Carmona Iragui M, Fortea J, Mufson EJ, Sabbagh M, Mohammed AH, Hartley D, Doran E, et al. Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27755974 DOI: 10.1016/j.jalz.2016.08.012 |
0.653 |
|
| 2015 |
Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Carroll SL, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157 |
0.396 |
|
| 2011 |
Liu RM, van Groen T, Katre A, Cao D, Kadisha I, Ballinger C, Wang L, Carroll SL, Li L. Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease. Neurobiology of Aging. 32: 1079-89. PMID 19604604 DOI: 10.1016/j.neurobiolaging.2009.06.003 |
0.429 |
|
| 2003 |
Chaudhury AR, Gerecke KM, Wyss JM, Morgan DG, Gordon MN, Carroll SL. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 62: 42-54. PMID 12528817 DOI: 10.1093/Jnen/62.1.42 |
0.538 |
|
| 2000 |
Honig LS, Chambliss DD, Bigio EH, Carroll SL, Elliott JL. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls. Neurology. 55: 1082-8. PMID 11071482 DOI: 10.1212/Wnl.55.8.1082 |
0.317 |
|
| Show low-probability matches. |
